logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Charlie Gourley

University of Edinburgh

60H指数
462论文数
2.4W被引数
收录论文 107
发表时间
logo
Long-term efficacy and safety of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201奥拉帕尼联合达芬钦在复发性低级别浆液性卵巢癌中的长期疗效与安全性：ENGOT-OV60/GOG-3052/RAMP 201研究2年随访结果
errGynecologic Oncology
IF4.1
err2026-09-01
err0
PREAI
errGrisham, Rachel N.; Van Nieuwenhuysen, Els; Santin, Alessandro D.; D'Hondt, Veronique; Thaker, Premal H.; Clamp, Andrew R.; Moore, Kathleen N.; Aghajanian, Carol; Oaknin, Ana; O'Malley, David M.; Monk, Bradley J.; Colombo, Nicoletta; Prendergast, Emily N.; Ring, Kari L.; Ray-Coquard, Isabelle; Rose, Peter G.; Gourley, Charlie; Holloway, Robert W.; Chon, Hye Sook; Van Gorp, Toon; Youssou, Hagop; Salinas, Erin; Lustgarten, Stephanie; Banerjee, Susana N.
err分享
err收藏
The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201阿伐木单抗与德法他尼联用治疗复发性低级别浆液性卵巢癌：ENGOT-OV60/GOG-3052/RAMP 201 II期临床试验的通俗语言总结
errFuture Oncology
IF2.6
err2025-12-12
err0
errOAAI
errSusana N. Banerjee; Els Van Nieuwenhuysen; Carol Aghajanian; Véronique D’Hondt; Bradley J. Monk; Andrew Clamp; Emily Prendergast; Ana Oaknin; Kari Ring; Nicoletta Colombo; Robert W. Holloway; Manuel Rodrigues; Hye Sook Chon; Charlie Gourley; Alessandro D. Santin; Premal H. Thaker; Christine Gennigens; Gregg Newman; Erin Salinas; Hagop Youssoufian; Kathleen N. Moore; Stephanie Lustgarten; David M. O’Malley; Toon Van Gorp; Rachel N. Grisham
err分享
err收藏
Cyclin E1 as a driver of oncogenesis; high grade serous ovarian cancer as an exemplarCyclin E1 作为致癌驱动力；高级别浆液性卵巢癌作为范例
errCritical Reviews in Oncology/Hematology
IF0
err2025-12-09
err0
errOAAI
errSarah J Taylor; Charlie Gourley
err分享
err收藏
Spectrum and Impact of Mitochondrial DNA Mutations in Ovarian Cancer线粒体DNA突变在卵巢癌中的谱系及影响
errInternational Journal of Molecular Sciences 2025, Vol. 26, Page 11180
IF4.9
err2025-11-19
err0
errOAAI
errSamantha Su Ping Low; Laura Greaves; Ryan Silk; Colin A. Semple; Charlie Gourley
err分享
err收藏
Targeting DNA Damage Repair Pathways Beyond PARP Inhibition靶向DNA损伤修复通路：超越PARP抑制
errTargeted Oncology
IF4
err2025-11-15
err0
PREAI
errEve Merry; Charlie Gourley
err分享
err收藏
The role of neoadjuvant chemotherapy in advanced-stage clear cell ovarian cancer: A GCIG multi-institutional retrospective cohort study新辅助化疗在晚期透明细胞卵巢癌中的作用：一项GCIG多中心回顾性队列研究
errGynecologic Oncology
IF3.7
err2025-09-25
err0
PREAI
errSahana Somasegar; Jiaqi Zhang; Christina Fotopoulou; Diletta Fumagalli; Jalid Sehouli; Charlie Gourley; Michael Churchman; Elena Ioana Braicu; Amer Karam
err分享
err收藏
Genetic testing for BRCA1/2 variants in Northern African women with ovarian and breast cancers: a multicentre study of an under-represented ancestry北非女性卵巢癌和乳腺癌患者BRCA1/2变异的遗传检测：一项针对代表性不足人群的多中心研究
errESMO Open
IF8.3
err2025-07-25
err0
errOAAI
errK.S. Shohdy; L. Kassem; T. Elnahas; E.M. Barsoum; B. Gabriel; H. Elghazawy; S. Lasheen; C. Gourley; H.A. Azim
err分享
err收藏
A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients一项关于tilvestamab（BGB149）在复发、铂耐药、高级别浆液性卵巢癌（PROC）患者中的1b期、多中心、剂量递增、安全性和药代动力学研究
errBritish Journal of Cancer
IF6.8
err2025-07-22
err0
errOAAI
errKenneth Sooi; Tuan Zea Tan; Jae-Weon Kim; Jung Yun Lee; Byoung-Gie Kim; David Micklem; Akil Jackson; David J. Pinato; Charlie Gourley; Rebecca Kristeleit; Sarah P. Blagden; Line Bjorge; David Shao Peng Tan
err分享
err收藏
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer关于晚期卵巢癌维持治疗方案选择和护理模式的驱动因素共识
errInternational Journal of Gynecological Cancer
IF4.7
err2025-04-19
err0
errOAAI
errAlejandro Perez-Fidalgo; Barbara Schmalfeldt; Angela George; Charlie Gourley; Sandro Pignata; Domenica Lorusso; Maria Pilar Barretina-Ginesta; Ignacio Romero; Christoph Grimm; Toon Van Gorp; Maria Rossing; Dearbhaile C. Collins; Josefin Fernebro; Line Bjørge; Alexandra Leary; Thibault de la Motte Rouge; Philipp Harter; Christian Kurzeder; Joana Savva-Bordalo; Benoit You
err分享
err收藏
Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high grade serous carcinoma体细胞BRCA1/2突变与生殖系对应突变在输卵管-卵巢高级别浆液性癌中具有相似的生存优势。
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2025-03-01
err0
PREAI
errHollis, Robert L.; Churchman, Michael; Grimes, Graeme R.; Meynert, Alison M.; Gautier, Philippe; Mcmahon, Lynn; Sherwood, Kitty; Oswald, Ailsa J.; Croy, Ian; Ferguson, Michelle; Martin, Cameron W.; Mcgoldrick, Trevor; Mcphail, Neil; Creedon, Helen; Barrett, J. Carl; March, Ruth; Dougherty, Brian A.; Roxburgh, Patricia; Ewing, Ailith; Herrington, C. Simon; Semple, Colin A.; Gourley, Charlie
err分享
err收藏
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial帕博利珠单抗治疗晚期透明细胞妇科癌症患者：一项II期非随机临床试验
errJAMA ONCOLOGY
IF20.1
err2025-02-06
err0
errOAAI
errKristeleit, Rebecca; Devlin, Michael-John; Clamp, Andrew; Gourley, Charlie; Roux, Rene; Hall, Marcia; Nirsimloo, Rachel; Kounnis, Valentinos; Sage, Lesley; Narayanan, Priya; Herrington, C. Simon; Arora, Rupali; Farrelly, Laura; Hughes, Laura; Miller, Rowan E.
err分享
err收藏
Histopathological Analysis Of High Grade Serous Ovarian Cancer (HGSOC) Using Artificial Intelligence Quantified Tumour Stroma Proportion (TSP)使用人工智能量化肿瘤基质比例(TSP)对高级别浆液性卵巢癌(HGSOC)进行组织病理学分析
errINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
err2025-02-01
err0
PREAI
errLim, Jessica Hui Cheah; Lim, Joanne Hui Yee; Sharif, Amana; Gourley, Charlie
err分享
err收藏
Controversies in the management of serous borderline tumors and low-grade serous ovarian cancer浆液性交界性肿瘤和低级别浆液性卵巢癌的管理争议
errINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
err2025-01-01
err0
errOAAI
errIlenkovan, Narthana; Ryan, Neil; Roxburgh, Patricia; Bell, Sarah; Gourley, Charlie
err分享
err收藏
Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib在评估奥拉帕尼的六项临床试验中，超过2000名卵巢癌患者的基因组不稳定性模式
errGENOME MEDICINE
IF11.2
err2024-12-18
err0
errOAAI
errBarnicle, Alan; Ray-Coquard, Isabelle; Rouleau, Etienne; Cadoo, Karen; Simpkins, Fiona; Aghajanian, Carol; Leary, Alexandra; Poveda, Andres; Lheureux, Stephanie; Pujade-Lauraine, Eric; You, Benoit; Ledermann, Jonathan; Matulonis, Ursula; Gourley, Charlie; Timms, Kirsten M.; Lai, Zhongwu; Hodgson, Darren R.; Elks, Cathy E.; Dearden, Simon; Egile, Coumaran; Lao-Sirieix, Pierre; Harrington, Elizabeth A.; Brown, Jessica S.
err分享
err收藏
Structural variants of BRCA1/2 represent a novel biomarker of homologous recombination deficiency in multiple tumour types
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-10-01
err0
PREAI
errOswald, A.; Hollis, R. L.; Carragher, N. O.; Albertella, M.; Forment, J. V.; Illuzzi, G.; Leo, E.; Elliott, R.; Gourley, C.
err分享
err收藏
Whole exome sequencing reveals diverse genomic relatedness between paired concurrent endometrial and ovarian carcinomas
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-09-01
err0
errOAAI
errSouthworth, Emily; Thomson, John P.; Croy, Ian; Churchman, Michael; Arends, Mark J.; Hollis, Robert L.; Gourley, Charlie; Herrington, C. Simon
err分享
err收藏
RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer
errFRONTIERS IN ONCOLOGY
IF3.3
err2024-04-22
err0
errOAAI
errTaylor, Sarah J.; Hollis, Robert L.; Gourley, Charlie; Herrington, C. Simon; Langdon, Simon P.; Arends, Mark J.
err分享
err收藏
The Oxford Classic can identify HGSOC patients who may benefit from EMT-targeting therapies
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errRai, Lena; Ravaggi, Antonella; Bignotti, Eliana; Hollis, Robb; Nulsen, Joel; Campo, Leticia; Easton, Alistair; Artibani, Mara; Churchman, Mike; Ferrari, Federico; Yau, Christopher; Gourley, Charlie; Odicino, Franco; Ahmed, Ahmed
err分享
err收藏
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseESGO-ESMO-ESP共识会议关于卵巢癌的建议: 病理学和分子生物学以及早期，晚期和复发性疾病
errANNALS OF ONCOLOGY
IF65.4
err2024-03-01
err46
errOAAI
errLedermann, J. A.; Matias-Guiu, X.; Amant, F.; Concin, N.; Davidson, B.; Fotopoulou, C.; Gonzalez-Martin, A.; Gourley, C.; Leary, A.; Lorusso, D.; Banerjee, S.; Chiva, L.; Cibula, D.; Colombo, N.; Croce, S.; Eriksson, A. G.; Falandry, C.; Fischerova, D.; Harter, P.; Joly, F.; Lazaro, C.; Lok, C.; Mahner, S.; Marme, F.; Marth, C.; McCluggage, W. G.; Mcneish, I. A.; Morice, P.; Nicum, S.; Oaknin, A.; Perez-Fidalgo, J. A.; Pignata, S.; Ramirez, P. T.; Ray-Coquard, I.; Romero, I.; Scambia, G.; Sehouli, J.; Shapira-Frommer, R.; Sundar, S.; Tan, D. S. P.; Taskiran, C.; van Driel, W. J.; Vergote, I.; Planchamp, F.; Sessa, C.; Fagotti, A.
err分享
err收藏
Current Applications and Challenges of Next-Generation Sequencing in Plasma Circulating Tumour DNA of Ovarian Cancer新一代测序技术在卵巢癌血浆循环肿瘤DNA中的应用现状及挑战
errBIOLOGY-BASEL
IF3.5
err2024-01-31
err3
errOAAI
errRoque, Ricardo; Ribeiro, Ilda Patricia; Figueiredo-Dias, Margarida; Gourley, Charlie; Carreira, Isabel Marques
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
G
Gordon B. Mills
H 指数: 231 · 论文数: 3.5K
A
Anil K. Sood
H 指数: 174 · 论文数: 3.3K
F
Freddie Bray
H 指数: 157 · 论文数: 705
P
Paul D.P. Pharoah
H 指数: 150 · 论文数: 1.8K
D
David G. Huntsman
H 指数: 147 · 论文数: 1.1K
查看更多